⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for TAilored Post-Surgical Therapy in Early Stage NSCLC

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: TAilored Post-Surgical Therapy in Early Stage NSCLC

Official Title: Randomized Phase II/III Adjuvant Trial Evaluating Feasibility of Standard (A) vs. Customized Treatment (B) in Stage II or Stage IIIA Non-N2, Non-squamous Non Small Cell Lung Cancer (NSCLC).

Study ID: NCT00775385

Study Description

Brief Summary: Our hypothesis is that patients receiving therapy based on their baseline tumor ERCC1 levels and EGFR mutations would attain better disease free survival rates than patients in the control arm receiving noncustomized therapy. Using this selective approach, patients with stage II and IIIA non N2 NSCLC in the genotypic arm with low ERCC1 levels will receive cisplatin plus pemetrexed, and those with high ERCC1 levels will not receive cisplatin-based chemotherapy. If they harbor EGRF mutations they will be treated with erlotinib. The study will be restricted to non-squamous NSCLC for two mains reasons. First, this will enrich the EGFR mutation rate that is awaited to be higher in these tumors than in squamous cell carcinoma. Second, permetrexed cisplatin combination has a promising efficacy and favorable toxicity profile and is of potential interest in the adjuvant setting of resected non-squamous NSCLC.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Centre Hospitalier, Aix en Provence, , France

Clinique de L'Europe, Amiens, , France

Angers - CHU, Angers, , France

Centre Hospitalier, Béziers, , France

Centre F. Baclesse, Caen, , France

CHU - Pneumologie, Caen, , France

Centre Hospitalier, Chauny, , France

Chevilly Larue - CH, Chevilly Larue, , France

Hôpital Percy-Armées - Pneumologie, Clamart, , France

Clermont Ferrand - CHU, Clermont Ferrand, , France

Colmar - CH, Colmar, , France

Dax - CH, Dax, , France

Ermont - Clinique Claude Bernard, Ermont, , France

CHU Grenoble - pneumologie, Grenoble, , France

Le Mans - CHG, Le Mans, , France

Centre Léon Bérard, Lyon, , France

Lyon - Hôpital Louis Pradel (Pneumologie), Lyon, , France

Mantes La Jolie - CH, Mantes La Jolie, , France

APHM - Hôpital Sainte Marguerite, Marseille, , France

Institut Paoli Calmette, Marseille, , France

Metz - Belle Isle, Metz, , France

Mont de Marsan - CH, Mont de Marsan, , France

Montpellier - Clinique Clémentville, Montpellier, , France

Mulhouse - CH, Mulhouse, , France

Nancy - Polyclinique Gentilly, Nancy, , France

Nevers - CH, Nevers, , France

Paris - Saint Louis, Paris, , France

APHP - Hopital Tenon - Pneumologie, Paris, , France

Pau - CH, Pau, , France

HCL - Lyon Sud (Pneumologie), Pierre Bénite, , France

Reims - CHU, Reims, , France

Rennes - CHU, Rennes, , France

Centre Hospitalier, Saint-Quentin, , France

Nouvel Hopital Civil, Strasbourg, , France

Hôpital Foch, Suresnes, , France

Centre Hospitalier Intercommunal, Toulon, , France

CHU Toulouse - Pneumologie, Toulouse, , France

Clinique Pasteur, Toulouse, , France

Tours - CHU, Tours, , France

Nancy - CHU, Vandoeuvre lès Nancy, , France

Institut Gustave Roussy, Villejuif, , France

Centre Hospitalier Intercommunal, Villeneuve-Saint-Georges, , France

Contact Details

Name: Jean-Charles SORIA, Pr

Affiliation: Institut Gustave Roussy (IGR)

Role: PRINCIPAL_INVESTIGATOR

Name: Marie Wislez, Pr

Affiliation: APHP - Hôpital Tenon (Paris)

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: